Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12547Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kwong, Jason C | - |
| dc.contributor.author | Grayson, M Lindsay | - |
| dc.date.accessioned | 2015-05-16T02:15:33Z | - |
| dc.date.available | 2015-05-16T02:15:33Z | - |
| dc.date.issued | 2015-01-01 | - |
| dc.identifier.citation | The Lancet. Infectious Diseases; 15(1): 14-5 | en_US |
| dc.identifier.other | PUBMED | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/12547 | en |
| dc.language.iso | en | en |
| dc.subject.other | Anti-HIV Agents.administration & dosage | en |
| dc.subject.other | Antiretroviral Therapy, Highly Active.methods | en |
| dc.subject.other | Female | en |
| dc.subject.other | HIV Infections.drug therapy | en |
| dc.subject.other | Humans | en |
| dc.subject.other | Male | en |
| dc.subject.other | Tuberculosis, Pulmonary.drug therapy | en |
| dc.title | TB-HAART trial. | en_US |
| dc.type | Journal Article | en_US |
| dc.identifier.journaltitle | The Lancet. Infectious Diseases | en_US |
| dc.identifier.affiliation | Infectious Diseases | en_US |
| dc.identifier.doi | 10.1016/S1473-3099(14)71032-1 | en_US |
| dc.description.pages | 14-5 | en |
| dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/25541161 | en |
| dc.type.content | Text | en_US |
| dc.type.austin | Journal Article | en |
| local.name.researcher | Grayson, M Lindsay | |
| item.fulltext | No Fulltext | - |
| item.grantfulltext | none | - |
| item.languageiso639-1 | en | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.cerifentitytype | Publications | - |
| item.openairetype | Journal Article | - |
| crisitem.author.dept | Infectious Diseases | - |
| crisitem.author.dept | Infectious Diseases | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.